Exclusive

Publication

Byline

ADB approves $139.55 million loan to enhance urban services in Puducherry

New Delhi, Oct. 31 -- The Asian Development Bank (ADB) has approved a $139.55 million loan to improve urban service delivery and municipal governance in Puducherry, benefiting over 320,000 people. Th... Read More


From 12 lakh to 90 lakh: SEBI chief reveals West Bengal's 7-fold investor boom

Kolkata/IBNS, Oct. 31 -- Securities and Exchange Board of India (SEBI) Chairman Tuhin Kanta Pandey on Saturday spoke on the rising number of investors in the state, the improved ease of doing business... Read More


Dollex Agrotech to announce Quarterly Result

Mumbai, Oct. 31 -- Dollex Agrotech will hold a meeting of the Board of Directors of the Company on 4 November 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


Eastcoast Steel to discuss results

Mumbai, Oct. 31 -- Eastcoast Steel will hold a meeting of the Board of Directors of the Company on 6 November 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


OMRON Healthcare Begins Full-Scale Production at First Factory in India

New Delhi, Oct. 31 -- Chennai Factory strengthens domestic blood pressure monitor supply and supports preventive cardiovascular care in India Chennai (Tamil Nadu) [India], October 31: ... Read More


PM Modi pays floral tribute to Sardar Patel on his 151st birth anniversary at Statue of Unity

New Delhi, Oct. 31 -- Prime Minister Narendra Modi paid floral tributes to the Iron Man of India, Sardar Vallabhbhai Patel, at the Statue of Unity in Ekta Nagar, Narmada district of Gujarat, on his 15... Read More


2 foreigners die in Bengaluru hotel pool 'shock'

Dhaka, Oct. 31 -- A German and a Slovak national have died after a suspected electric shock in the swimming pool of a luxury hotel in India's Bengaluru. Indian police said the incident took place on ... Read More


Samor Reality to hold board meeting

Mumbai, Oct. 31 -- Samor Reality will hold a meeting of the Board of Directors of the Company on 6 November 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More